Apexigen Announces New Phase 2 Clinical Data on CD40 Antibody Sotigalimab at the SITC 2021 Annual Meeting

NEXT STORY
Mustang Bio Reports Third Quarter 2021 Financial Results and Recent Corporate Highlights
PREV STORY
Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Glycotope Selects CrownBio as a Preclinical Development Partner to Advance Their Immunotherapeutic Pipeline

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of ...

author_avatar
NASDAQ Market News

Karmanos Expands Cancer Network with Newest Location at McLaren Oakland

Oncologists Jeffrey Margolis, M.D., and Adil Akhtar, M.D., to join Karmanos and Lead Oakland ...

author_avatar
NASDAQ Market News

Stemline Therapeutics Presents SL-801 Phase 1 Data at ESMO 2017

NEW YORK, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

author_avatar
NASDAQ Market News